Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Leukemia, Myeloid × Thiotepa × Clear all

Phase

Status

Unknown 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Breast Neoplasms 4 Lymphoma, Non-Hodgkin 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Lymphoma 2 Inflammatory Breast Neoplasms 2 Central Nervous System Neoplasms 2 Brain Neoplasms 2 Rhabdoid Tumor 1 Ovarian Neoplasms 1 Oligodendroglioma 1 Neuroectodermal Tumors, Primitive 1 Neuroblastoma 1 Multiple Myeloma 1 Medulloblastoma 1 Lymphoma, Large-Cell, Anaplastic 1 Leukemia, Myeloid, Acute 1 Leukemia, Myeloid 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Intracranial Non-germinomatous Germ Cell Tumor 1 Hodgkin Disease 1 Graft vs Host Disease 1 Fallopian Tube Neoplasms 1 Choroid Plexus Neoplasms 1 Carcinoma, Ovarian Epithelial 1 Astrocytoma 1

Interventions

Immunotherapy, Adoptive 2 flumatinib 1 fludarabine 1 Thiotepa 1 Sensitivity and Specificity 1 Imatinib Mesylate 1 Idarubicin 1 Diagnosis 1 Deferasirox 1 Decitabine 1 Daunorubicin 1 Cytarabine 1 Cladribine 1 Busulfan 1 Blood Specimen Collection 1 Azacitidine 1 Anthracyclines 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02333838 2018-08-13

TBF-Cord

Assistance Publique - Hôpitaux de Paris

Phase 2 Unknown

Other hematologic neoplasm

Leukemia, Myeloid

Data powered by HemOnc (CC BY 4.0) Colophon ⚡